Baker backs rate-setting for high-cost drugs

Proposal gives roles to Health Policy Commission, AG

THE BAKER ADMINISTRATION is seeking legislative authority for MassHealth to negotiate prices directly with the manufacturers of high-cost drugs that have little or no competition and, if that effort fails to produce savings, to put the companies through a rate-setting process followed by regulatory and legal penalties if the firm fails to charge the target(...)

Read More »